INDP
Indaptus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.55
−9.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 4.61x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 41.59x
- Price / sales
- —
- Price / cash flow
- -31.15x
Enterprise value
- Enterprise value
- $461.5M
- EV / sales
- —
- EV / EBITDA
- -29.86x
- EV / EBIT
- -31.24x
- Market cap
- $473.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026